Patritumab deruxtecan shows activity in EGFR-mutant NSCLC
Crossref DOI link: https://doi.org/10.1038/s41571-023-00822-6
Published Online: 2023-09-25
Published Print: 2023-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2023-09-25
Version of Record valid from 2023-09-25
Article History
First Online: 25 September 2023